Global Needle-free Injection Systems Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
ReportID: 543140
|
Published Date: 2024/07/06
|
No. of Pages: 165
|
Categories: Life Sciences
|
Format : 
The global Needle-free Injection Systems market was valued at 169.49 Million USD in 2020 and will grow with a CAGR of 5.19% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems. Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 60% of the market. North America is the larest market, with a share over 60%. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 50%.
By Market Verdors:
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
DAntonio Consultants International
Lepu Medical
TECHiJET
By Types:
Reusable Injector
Single-use Injector
By Applications:
Vaccine Delivery
Insulin Delivery
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems. Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 60% of the market. North America is the larest market, with a share over 60%. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 50%.
By Market Verdors:
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
DAntonio Consultants International
Lepu Medical
TECHiJET
By Types:
Reusable Injector
Single-use Injector
By Applications:
Vaccine Delivery
Insulin Delivery
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Needle-free Injection Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Needle-free Injection Systems Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Reusable Injector
1.4.3 Single-use Injector
1.5 Market by Application
1.5.1 Global Needle-free Injection Systems Market Share by Application: 2022-2027
1.5.2 Vaccine Delivery
1.5.3 Insulin Delivery
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Needle-free Injection Systems Market
1.8.1 Global Needle-free Injection Systems Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Needle-free Injection Systems Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Needle-free Injection Systems Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Needle-free Injection Systems Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Needle-free Injection Systems Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Needle-free Injection Systems Sales Volume Market Share by Region (2016-2021)
3.2 Global Needle-free Injection Systems Sales Revenue Market Share by Region (2016-2021)
3.3 North America Needle-free Injection Systems Sales Volume
3.3.1 North America Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.3.2 North America Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Needle-free Injection Systems Sales Volume
3.4.1 East Asia Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Needle-free Injection Systems Sales Volume (2016-2021)
3.5.1 Europe Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Needle-free Injection Systems Sales Volume (2016-2021)
3.6.1 South Asia Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Needle-free Injection Systems Sales Volume (2016-2021)
3.7.1 Southeast Asia Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Needle-free Injection Systems Sales Volume (2016-2021)
3.8.1 Middle East Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Needle-free Injection Systems Sales Volume (2016-2021)
3.9.1 Africa Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Needle-free Injection Systems Sales Volume (2016-2021)
3.10.1 Oceania Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Needle-free Injection Systems Sales Volume (2016-2021)
3.11.1 South America Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.11.2 South America Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Needle-free Injection Systems Sales Volume (2016-2021)
3.12.1 Rest of the World Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Needle-free Injection Systems Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Needle-free Injection Systems Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Needle-free Injection Systems Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Needle-free Injection Systems Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Needle-free Injection Systems Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Needle-free Injection Systems Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Needle-free Injection Systems Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Needle-free Injection Systems Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Needle-free Injection Systems Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Needle-free Injection Systems Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Needle-free Injection Systems Sales Volume Market Share by Type (2016-2021)
14.2 Global Needle-free Injection Systems Sales Revenue Market Share by Type (2016-2021)
14.3 Global Needle-free Injection Systems Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Needle-free Injection Systems Consumption Volume by Application (2016-2021)
15.2 Global Needle-free Injection Systems Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Needle-free Injection Systems Business
16.1 Antares Pharma
16.1.1 Antares Pharma Company Profile
16.1.2 Antares Pharma Needle-free Injection Systems Product Specification
16.1.3 Antares Pharma Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Endo International plc
16.2.1 Endo International plc Company Profile
16.2.2 Endo International plc Needle-free Injection Systems Product Specification
16.2.3 Endo International plc Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Inovio Pharmaceuticals
16.3.1 Inovio Pharmaceuticals Company Profile
16.3.2 Inovio Pharmaceuticals Needle-free Injection Systems Product Specification
16.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Injex Pharma
16.4.1 Injex Pharma Company Profile
16.4.2 Injex Pharma Needle-free Injection Systems Product Specification
16.4.3 Injex Pharma Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 National Medical Products Inc (J-Tip)
16.5.1 National Medical Products Inc (J-Tip) Company Profile
16.5.2 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product Specification
16.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Recipharm
16.6.1 Recipharm Company Profile
16.6.2 Recipharm Needle-free Injection Systems Product Specification
16.6.3 Recipharm Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 European Pharma Group (InsuJet)
16.7.1 European Pharma Group (InsuJet) Company Profile
16.7.2 European Pharma Group (InsuJet) Needle-free Injection Systems Product Specification
16.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Miracle Medical
16.8.1 Miracle Medical Company Profile
16.8.2 Miracle Medical Needle-free Injection Systems Product Specification
16.8.3 Miracle Medical Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Medical International Technology (MIT)
16.9.1 Medical International Technology (MIT) Company Profile
16.9.2 Medical International Technology (MIT) Needle-free Injection Systems Product Specification
16.9.3 Medical International Technology (MIT) Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Akra Dermojet
16.10.1 Akra Dermojet Company Profile
16.10.2 Akra Dermojet Needle-free Injection Systems Product Specification
16.10.3 Akra Dermojet Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 PharmaJet
16.11.1 PharmaJet Company Profile
16.11.2 PharmaJet Needle-free Injection Systems Product Specification
16.11.3 PharmaJet Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Portal Instruments
16.12.1 Portal Instruments Company Profile
16.12.2 Portal Instruments Needle-free Injection Systems Product Specification
16.12.3 Portal Instruments Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Crossject Medical Technology
16.13.1 Crossject Medical Technology Company Profile
16.13.2 Crossject Medical Technology Needle-free Injection Systems Product Specification
16.13.3 Crossject Medical Technology Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 MIKA MEDICAL
16.14.1 MIKA MEDICAL Company Profile
16.14.2 MIKA MEDICAL Needle-free Injection Systems Product Specification
16.14.3 MIKA MEDICAL Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Ferring Pharmaceuticals
16.15.1 Ferring Pharmaceuticals Company Profile
16.15.2 Ferring Pharmaceuticals Needle-free Injection Systems Product Specification
16.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 DAntonio Consultants International
16.16.1 DAntonio Consultants International Company Profile
16.16.2 DAntonio Consultants International Needle-free Injection Systems Product Specification
16.16.3 DAntonio Consultants International Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Lepu Medical
16.17.1 Lepu Medical Company Profile
16.17.2 Lepu Medical Needle-free Injection Systems Product Specification
16.17.3 Lepu Medical Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 TECHiJET
16.18.1 TECHiJET Company Profile
16.18.2 TECHiJET Needle-free Injection Systems Product Specification
16.18.3 TECHiJET Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Needle-free Injection Systems Manufacturing Cost Analysis
17.1 Needle-free Injection Systems Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Needle-free Injection Systems
17.4 Needle-free Injection Systems Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Needle-free Injection Systems Distributors List
18.3 Needle-free Injection Systems Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Needle-free Injection Systems (2022-2027)
20.2 Global Forecasted Revenue of Needle-free Injection Systems (2022-2027)
20.3 Global Forecasted Price of Needle-free Injection Systems (2016-2027)
20.4 Global Forecasted Production of Needle-free Injection Systems by Region (2022-2027)
20.4.1 North America Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.3 Europe Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.7 Africa Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.9 South America Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Needle-free Injection Systems by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Needle-free Injection Systems by Country
21.2 East Asia Market Forecasted Consumption of Needle-free Injection Systems by Country
21.3 Europe Market Forecasted Consumption of Needle-free Injection Systems by Countriy
21.4 South Asia Forecasted Consumption of Needle-free Injection Systems by Country
21.5 Southeast Asia Forecasted Consumption of Needle-free Injection Systems by Country
21.6 Middle East Forecasted Consumption of Needle-free Injection Systems by Country
21.7 Africa Forecasted Consumption of Needle-free Injection Systems by Country
21.8 Oceania Forecasted Consumption of Needle-free Injection Systems by Country
21.9 South America Forecasted Consumption of Needle-free Injection Systems by Country
21.10 Rest of the world Forecasted Consumption of Needle-free Injection Systems by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Needle-free Injection Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Needle-free Injection Systems Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Reusable Injector
1.4.3 Single-use Injector
1.5 Market by Application
1.5.1 Global Needle-free Injection Systems Market Share by Application: 2022-2027
1.5.2 Vaccine Delivery
1.5.3 Insulin Delivery
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Needle-free Injection Systems Market
1.8.1 Global Needle-free Injection Systems Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Needle-free Injection Systems Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Needle-free Injection Systems Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Needle-free Injection Systems Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Needle-free Injection Systems Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Needle-free Injection Systems Sales Volume Market Share by Region (2016-2021)
3.2 Global Needle-free Injection Systems Sales Revenue Market Share by Region (2016-2021)
3.3 North America Needle-free Injection Systems Sales Volume
3.3.1 North America Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.3.2 North America Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Needle-free Injection Systems Sales Volume
3.4.1 East Asia Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Needle-free Injection Systems Sales Volume (2016-2021)
3.5.1 Europe Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Needle-free Injection Systems Sales Volume (2016-2021)
3.6.1 South Asia Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Needle-free Injection Systems Sales Volume (2016-2021)
3.7.1 Southeast Asia Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Needle-free Injection Systems Sales Volume (2016-2021)
3.8.1 Middle East Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Needle-free Injection Systems Sales Volume (2016-2021)
3.9.1 Africa Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Needle-free Injection Systems Sales Volume (2016-2021)
3.10.1 Oceania Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Needle-free Injection Systems Sales Volume (2016-2021)
3.11.1 South America Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.11.2 South America Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Needle-free Injection Systems Sales Volume (2016-2021)
3.12.1 Rest of the World Needle-free Injection Systems Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Needle-free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Needle-free Injection Systems Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Needle-free Injection Systems Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Needle-free Injection Systems Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Needle-free Injection Systems Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Needle-free Injection Systems Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Needle-free Injection Systems Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Needle-free Injection Systems Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Needle-free Injection Systems Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Needle-free Injection Systems Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Needle-free Injection Systems Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Needle-free Injection Systems Sales Volume Market Share by Type (2016-2021)
14.2 Global Needle-free Injection Systems Sales Revenue Market Share by Type (2016-2021)
14.3 Global Needle-free Injection Systems Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Needle-free Injection Systems Consumption Volume by Application (2016-2021)
15.2 Global Needle-free Injection Systems Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Needle-free Injection Systems Business
16.1 Antares Pharma
16.1.1 Antares Pharma Company Profile
16.1.2 Antares Pharma Needle-free Injection Systems Product Specification
16.1.3 Antares Pharma Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Endo International plc
16.2.1 Endo International plc Company Profile
16.2.2 Endo International plc Needle-free Injection Systems Product Specification
16.2.3 Endo International plc Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Inovio Pharmaceuticals
16.3.1 Inovio Pharmaceuticals Company Profile
16.3.2 Inovio Pharmaceuticals Needle-free Injection Systems Product Specification
16.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Injex Pharma
16.4.1 Injex Pharma Company Profile
16.4.2 Injex Pharma Needle-free Injection Systems Product Specification
16.4.3 Injex Pharma Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 National Medical Products Inc (J-Tip)
16.5.1 National Medical Products Inc (J-Tip) Company Profile
16.5.2 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product Specification
16.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Recipharm
16.6.1 Recipharm Company Profile
16.6.2 Recipharm Needle-free Injection Systems Product Specification
16.6.3 Recipharm Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 European Pharma Group (InsuJet)
16.7.1 European Pharma Group (InsuJet) Company Profile
16.7.2 European Pharma Group (InsuJet) Needle-free Injection Systems Product Specification
16.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Miracle Medical
16.8.1 Miracle Medical Company Profile
16.8.2 Miracle Medical Needle-free Injection Systems Product Specification
16.8.3 Miracle Medical Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Medical International Technology (MIT)
16.9.1 Medical International Technology (MIT) Company Profile
16.9.2 Medical International Technology (MIT) Needle-free Injection Systems Product Specification
16.9.3 Medical International Technology (MIT) Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Akra Dermojet
16.10.1 Akra Dermojet Company Profile
16.10.2 Akra Dermojet Needle-free Injection Systems Product Specification
16.10.3 Akra Dermojet Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 PharmaJet
16.11.1 PharmaJet Company Profile
16.11.2 PharmaJet Needle-free Injection Systems Product Specification
16.11.3 PharmaJet Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Portal Instruments
16.12.1 Portal Instruments Company Profile
16.12.2 Portal Instruments Needle-free Injection Systems Product Specification
16.12.3 Portal Instruments Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Crossject Medical Technology
16.13.1 Crossject Medical Technology Company Profile
16.13.2 Crossject Medical Technology Needle-free Injection Systems Product Specification
16.13.3 Crossject Medical Technology Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 MIKA MEDICAL
16.14.1 MIKA MEDICAL Company Profile
16.14.2 MIKA MEDICAL Needle-free Injection Systems Product Specification
16.14.3 MIKA MEDICAL Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Ferring Pharmaceuticals
16.15.1 Ferring Pharmaceuticals Company Profile
16.15.2 Ferring Pharmaceuticals Needle-free Injection Systems Product Specification
16.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 DAntonio Consultants International
16.16.1 DAntonio Consultants International Company Profile
16.16.2 DAntonio Consultants International Needle-free Injection Systems Product Specification
16.16.3 DAntonio Consultants International Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Lepu Medical
16.17.1 Lepu Medical Company Profile
16.17.2 Lepu Medical Needle-free Injection Systems Product Specification
16.17.3 Lepu Medical Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 TECHiJET
16.18.1 TECHiJET Company Profile
16.18.2 TECHiJET Needle-free Injection Systems Product Specification
16.18.3 TECHiJET Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Needle-free Injection Systems Manufacturing Cost Analysis
17.1 Needle-free Injection Systems Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Needle-free Injection Systems
17.4 Needle-free Injection Systems Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Needle-free Injection Systems Distributors List
18.3 Needle-free Injection Systems Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Needle-free Injection Systems (2022-2027)
20.2 Global Forecasted Revenue of Needle-free Injection Systems (2022-2027)
20.3 Global Forecasted Price of Needle-free Injection Systems (2016-2027)
20.4 Global Forecasted Production of Needle-free Injection Systems by Region (2022-2027)
20.4.1 North America Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.3 Europe Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.7 Africa Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.9 South America Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Needle-free Injection Systems Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Needle-free Injection Systems by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Needle-free Injection Systems by Country
21.2 East Asia Market Forecasted Consumption of Needle-free Injection Systems by Country
21.3 Europe Market Forecasted Consumption of Needle-free Injection Systems by Countriy
21.4 South Asia Forecasted Consumption of Needle-free Injection Systems by Country
21.5 Southeast Asia Forecasted Consumption of Needle-free Injection Systems by Country
21.6 Middle East Forecasted Consumption of Needle-free Injection Systems by Country
21.7 Africa Forecasted Consumption of Needle-free Injection Systems by Country
21.8 Oceania Forecasted Consumption of Needle-free Injection Systems by Country
21.9 South America Forecasted Consumption of Needle-free Injection Systems by Country
21.10 Rest of the world Forecasted Consumption of Needle-free Injection Systems by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Published On:2024/07/06
Base Year:
Historical Data:
No of Pages:165
Price
Global Needle-free Injection Systems Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
